Pyrazinamide Tablet
Product Images NDC 10135-735

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pyrazinamide (NDC 10135-735). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Marlex Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100ct (500 100ct)

100ct (500 100ct)
This is a description for Pyrazinamide tablets. Each tablet contains 500mg of the active ingredient. The usual adult dosage is 15-30 mo/kg once daily, not to exceed 2 g. The package literature should be consulted for more complete information. The tablets should be dispensed in a tight, light-resistant container and stored at 20° to 25°C (68° to 77°F). Controlled room temperature is recommended. This medication should be kept out of the reach of children. This product is manufactured and distributed by Marlex Pharmaceuticals, Inc. in New Castle, DE. The package contains 100 tablets.*
FDA Label Image

60count (500 60ct)

60count (500 60ct)
This is a medication with the name Pyrazinamide, USP. Each tablet contains 500mg of it. It is primarily used for adult dosage and must be consumed once daily via defined guidelines. The package contains detailed information about the medication. Pyrazinamide DS nston s conaer s is the name of the product, and it comes with a child-resistant closure. The medication must be stored in a controlled room temperature. It is not clear what the first line "0" denotes.*
FDA Label Image

90ct (500 90ct)

90ct (500 90ct)
This text describes a medication called Pyrazinamide in tablet form. It provides information on the usual adult dosage, precautions for use, such as the need to consult package literature, and how to store the medication. It also includes manufacturing and distribution information.*
FDA Label Image

Struct (Struct)

Struct (Struct)
This appears to be a chemical notation for a compound with a molecular weight of 123.11 g/mol and a formula of C₈H₁₁N₃O. However, without more context it is difficult to determine the identity or properties of the molecule.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.